CDKN2A and cancer: Importantly, p16INK4a is a key regulator of oncogene-induced senescence, especially in the context of oncogenic activation of the RAF/RAS/ERK pathway [197, 198] and is often deleted or inactivated through promoter hypermethylation in human cancers [199].